Laurion Capital Management’s Cantel Medical Corporation CMD Stock Holding History

Laurion Capital Management’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-42,042	Closed	-$1.51M	–	1265
2020 Q1	$1.51M	Buy	+42,042	New	+$2.39M	0.02%	397
2019 Q4	–	Sell	-3,900	Closed	-$292K	–	1336
2019 Q3	$292K	Buy	+3,900	New	+$331K	﹤0.01%	871
2019 Q2	–	Sell	-23,278	Closed	-$1.56M	–	1277
2019 Q1	$1.56M	Buy	+23,278	New	+$1.76M	0.02%	433
2018 Q1	–	Sell	-3,200	Closed	-$329K	–	1829
2017 Q4	$329K	Sell	3,200 -4,000	-56%	-$398K	﹤0.01%	1301
2017 Q3	$678K	Buy	+7,200	New	+$568K	﹤0.01%	1078

Other funds holding CMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

LGP

Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Laurion Capital Management's CMD Position: Q2 2020 in Review

Laurion Capital Management sold out of Cantel Medical Corporation (CMD) in Q2 2020, closing a stake of 42,042 shares — an estimated $1.51M sold.

Laurion Capital Management first reported a position in CMD in Q3 2017 and held it in 5 quarters. The position peaked at $1.56M in Q1 2019. 210 funds tracked by Wall St. Rank hold CMD as of Q2 2020.

Laurion Capital Management reported no remaining Cantel Medical Corporation position as of Q2 2020 after selling out during the quarter.
Laurion Capital Management sold 42,042 Cantel Medical Corporation shares in Q2 2020, an estimated $1.51M.
Laurion Capital Management first reported a position in Cantel Medical Corporation in Q3 2017 and held it in 5 quarters.
Laurion Capital Management's Cantel Medical Corporation position peaked at $1.56M in Q1 2019.
210 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2020.

Based on Laurion Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.